Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Immunogen (IMGN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: IMGN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on IMGN
Ohad Hammer
(176 followers)
Immunogen's Busy Month, Part II
(Wed, Dec 2)
Immunogen's Busy Month, Part I
(Tue, Dec 1)
Incyte: Life After Debt (Part I)
(Wed, Oct 14)
More by Ohad Hammer on IMGN »
Alan Brochstein
(711 followers)
Cancer Stocks Hammered Once Again
(Tue, Jun 26)
Cancer Stocks Slide Again
(Mon, Jun 18)
Cancer Stocks Plunge Following ASCO Meeting
(Mon, Jun 11)
More by Alan Brochstein on IMGN »
Beta Delta
(11 followers)
Immunogen: Moving on Up
(Fri, Mar 27)
Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer
(Tue, Jan 6)
Time to Buy ImmunoGen
(Thu, Dec 4)
More by Beta Delta on IMGN »
Most followed authors on IMGN
Mike Havrilla
(1942 followers)
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
(Mon, Jun 1)
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
(Mon, May 18)
FDA, Clinical Trial Calendar Updates: AstraZeneca Announces Phase III Results
(Tue, May 12)
More by Mike Havrilla on IMGN »
Marco Hickey
(1317 followers)
37 Breakout Stocks on Big Volume, November 16, 2009
(Tue, Nov 17)
More by Marco Hickey on IMGN »
J Clinton Hill
(978 followers)
20 'Bathwater Babies' and 3 'Dogs with Fleas' for the Week
(Mon, Mar 2)
More by J Clinton Hill on IMGN »
Newest authors on IMGN
Justin M. Hall
(672 followers)
December's Game Plan for Biotech
(Tue, Dec 1)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on IMGN »
M. E. Garza
(522 followers)
Healthcare Stocks Continue to Rise
(Fri, Jun 19)
More by M. E. Garza on IMGN »
The Burrill Report
(206 followers)
Three Life Science Companies Line Up for IPOs
(Mon, Sep 21)
Pharma M&A: Big Bonds and Small Deals
(Fri, Jun 26)
A Healthy Dose of Funding for Pharma, Biotech
(Sun, Jun 21)
More by The Burrill Report on IMGN »
Most commented on IMGN
Ohad Hammer
(176 followers)
Immunogen's Busy Month, Part II
(Wed, Dec 2)
Immunogen's Busy Month, Part I
(Tue, Dec 1)
Incyte: Life After Debt (Part I)
(Wed, Oct 14)
More by Ohad Hammer on IMGN »
Justin M. Hall
(672 followers)
December's Game Plan for Biotech
(Tue, Dec 1)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on IMGN »
Alan Brochstein
(711 followers)
Cancer Stocks Hammered Once Again
(Tue, Jun 26)
Cancer Stocks Slide Again
(Mon, Jun 18)
Cancer Stocks Plunge Following ASCO Meeting
(Mon, Jun 11)
More by Alan Brochstein on IMGN »